Table 5. NEI VFQ-25 subscale scores and OCS compared with literature.
| GH | GV | OP | NA | DA | VSSF | VSMH | VSRD | VSD | D | CV | PV | OCS* | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Study | Mean age ± SD (yrs) | Group composition | Mean (SD) | ||||||||||||
| Hoeksema | 55 ± 12 | HLA-B27 associated | 47.4 | 78.3 | 73.1 | 88.0 | 90.8 | 97.2 | 88.7 | 86.4 | 97.5 | 85.3 | 99.6 | 94.1 | 88.9 |
| n = 59 | anterior uveitis | (20.8) | (10.8) | (20.3) | (15.2) | (12.3) | (8.7) | (9.2) | (17.4) | (8.9) | (14.2) | (3.3) | (12.6) | (8.8) | |
| Hirneiss 200915 | 42 ± 9 | Normal working population | 73.0 | 78.6 | 85.4 | 91.9 | 91.8 | 97.9 | 87.4 | 92.8 | 98.4 | 88.7 | 97.9 | 93.3 | 91.1 |
| n = 619 | - Total group | (18.1) | (15.7) | (16.6) | (13.1) | (11.3) | (9.0) | (10.5) | (13.8) | (5.6) | (10.6) | (9.3) | (15.0) | (7.4) | |
| Hirneiss 200915 | 42 ± 9 | Normal working population | 79.9 | 79.0 | 87.6 | 92.3 | 92.1 | 98.1 | 87.8 | 93.4 | 98.5 | 88.8 | 98.0 | 93.4 | 91.6 |
| n = 511 | - Without ocular disease | (17.4) | (15.9) | (15.1) | (13.0) | (11.4) | (8.2) | (10.0) | (13.3) | (5.5) | (10.6) | (8.7) | (14.6) | (7.1) | |
| Hirneiss 200915 | 43 | Normal working population | 68.6 | 79.1 | 75.1 | 90.2 | 90.6 | 96.8 | 85.3 | 89.7 | 97.9 | 88.4 | 97.3 | 92.5 | 88.8 |
| n = 108 | - With ocular disease | (20.7) | (15.9) | (19.2) | (13.6) | (10.7) | (12.3) | (12.5) | (15.6) | (5.8) | (10.4) | (11.6) | (16.7) | (8.3) | |
| Hoeksema 20147 | 58 ± 17 | Herpetic anterior uveitis | 59.0 | 76.1 | 73.3 | 87.7 | 92.6 | 97.1 | 84.9 | 84.0 | 97.7 | 87.1 | 97.1 | 91.2 | 88.1 |
| n = 36 | (19.0) | (9.3) | (22.8) | (16.7) | (12.6) | (8.1) | (14.4) | (21.9) | (7.1) | (16.2) | (10.1) | (20.3) | (10.6) | ||
| Qian 20114 | 41 | Noninfectious ocular | 60.3 | 72.8 | 73.9 | 79.2 | 78.8 | 89.9 | 70.8 | 74.2 | 84.9 | 77.4 | 94.9 | 81.3 | 79.7 |
| n = 104 | inflammatory disease | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| Naik 20135 | - | Noninfectious intermediate | 59.1 | 70.3 | 76.5 | 78.9 | 80.5 | 87.8 | 71.2 | 75.3 | 86.7 | 81.2 | 92.8 | 83.4 | 80.3 |
| n = 123 | and posterior uveitis | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| (Snellen VA ≥ 0.5) | |||||||||||||||
| Kuiper 20136 | 59.5 (median) | Birdshot chorioretinopathy | 61.6 | 63.8 | 75.1 | 68.6 | 70.3 | 84.5 | 71.2 | 64.5 | 84.2 | 66.8 | 80.2 | 67.6 | 71.0 |
| n = 105 | - | - | - | - | - | - | - | - | - | - | - | - | - | ||
| Cahill 200514 | 76.4 ± 5.6 | Bilateral severe AMD | - | 31.4 | 81.8 | 29.4 | 38.8 | 58.4 | 34.1 | 38.2 | 42.7 | 16.1 | 67.5 | 66.8 | - |
| n = 70 | - | (15.8) | (20.3) | (18.6) | (24.7) | (28.1) | (25.1) | (27.1) | (29.7) | (31.3) | (27.7) | (25.1) | - | ||
NEI VFQ-25: National Eye Institute Visual Function Questionnaire-25. GH: General Health, GV: General Vision, OP: Ocular Pain, NA: Near Activities, DA: Distance Activities, VSSF: Vision Specific Social Functioning, VSMH: Vision Specific Mental Health, VSRD: Vision Specific Role Difficulties, VSD: Vision Specific Dependency, D: Driving, CV: Color Vision, PV: Peripheral Vision, OCS: Overall Composite Score, VA: visual acuity. AMD: age-related macular degeneration.
* Average of vision-targeted subscale scores, without GH.